Ditchcarbon
  • Contact
  1. Organizations
  2. DiaSorin Inc.
Public Profile
Research Pending

This profile hasn't yet passed our validation checks

Submit your email to push it up the queue

We'll prioritize this organization's research and notify you when detailed sustainability data becomes available.

Pharmaceutical Preparation Manufacturing
US
updated 20 days ago

DiaSorin Inc.

Company website

DiaSorin Inc., a prominent player in the diagnostics industry, is headquartered in the United States and operates extensively across Europe, Asia, and Latin America. Founded in 1968, the company has established itself as a leader in the development of innovative diagnostic solutions, particularly in the fields of infectious diseases, oncology, and endocrinology. With a diverse portfolio of products, DiaSorin is renowned for its unique immunodiagnostic assays and molecular diagnostics, which leverage advanced technology to deliver accurate and timely results. The company’s commitment to quality and innovation has positioned it favourably in the global market, earning recognition for its contributions to healthcare. Notable achievements include a robust pipeline of cutting-edge tests and a strong presence in both hospital and laboratory settings, making DiaSorin Inc. a trusted name in the diagnostics sector.

DitchCarbon Score

How does DiaSorin Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

36

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

32

Industry Benchmark

DiaSorin Inc.'s score of 36 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.

59%

Let us know if this data was useful to you

DiaSorin Inc.'s reported carbon emissions

Inherited from DiaSorin S.p.A.

DiaSorin Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of DiaSorin S.p.A., which may influence its climate commitments and emissions reporting. As of now, DiaSorin Inc. has not established any documented reduction targets or initiatives related to carbon emissions. The absence of specific emissions data and reduction commitments suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the lack of direct emissions data, it is important to note that DiaSorin Inc.'s climate commitments may be informed by the broader initiatives of its parent company, DiaSorin S.p.A. However, no specific targets or initiatives have been cascaded from the parent organisation that are publicly available. In summary, DiaSorin Inc. is currently without specific emissions data or reduction targets, reflecting a potential area for future development in their climate strategy.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2016201820192020202120222023
Scope 1
3,223,720
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 2
8,426,130
00,000,000
00,000,000
0,000,000
00,000,000
00,000,000
00,000,000
Scope 3
-
-
-
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. DiaSorin Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for DiaSorin Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

DiaSorin Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Accelerate Diagnostics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Abbott Rapid Diagnostics PTY LTD.

AU
•
Pharmaceutical Preparation Manufacturing
Updated 25 days ago

Roche Diagnostics Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

SD Biosensor, Inc

KR
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Copan Diagnostics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 25 days ago

Phadia

CZ
•
Health and social work services (85)
Updated 23 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251009.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy